371 related articles for article (PubMed ID: 30787215)
1. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus.
Randrianarisoa E; Lehn-Stefan A; Hieronimus A; Rietig R; Fritsche A; Machann J; Balletshofer B; Häring HU; Stefan N; Rittig K
J Atheroscler Thromb; 2019 Sep; 26(9):821-834. PubMed ID: 30787215
[TBL] [Abstract][Full Text] [Related]
2. Association Between the Visceral Adiposity Index and Homeostatic Model Assessment of Insulin Resistance in Participants With Normal Waist Circumference.
Ji B; Qu H; Wang H; Wei H; Deng H
Angiology; 2017 Sep; 68(8):716-721. PubMed ID: 28743220
[TBL] [Abstract][Full Text] [Related]
3. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
[No Abstract] [Full Text] [Related]
4. Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study.
Lehn-Stefan A; Peter A; Machann J; Schick F; Randrianarisoa E; Heni M; Wagner R; Birkenfeld AL; Fritsche A; Häring HU; Staiger H; Stefan N
J Clin Endocrinol Metab; 2021 Jan; 106(2):e982-e989. PubMed ID: 33277657
[TBL] [Abstract][Full Text] [Related]
5. Abdominal adiposity largely explains associations between insulin resistance, hyperglycemia and subclinical atherosclerosis: the NEO study.
Gast KB; Smit JW; den Heijer M; Middeldorp S; Rippe RC; le Cessie S; de Koning EJ; Jukema JW; Rabelink TJ; de Roos A; Rosendaal FR; de Mutsert R;
Atherosclerosis; 2013 Aug; 229(2):423-9. PubMed ID: 23880198
[TBL] [Abstract][Full Text] [Related]
6. Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: The NEO study.
Gast KB; den Heijer M; Smit JW; Widya RL; Lamb HJ; de Roos A; Jukema JW; Rosendaal FR; de Mutsert R;
Atherosclerosis; 2015 Aug; 241(2):547-54. PubMed ID: 26100677
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance is associated with carotid intima-media thickness in non-diabetic subjects. A cross-sectional analysis of the ELSA-Brasil cohort baseline.
Santos IS; Bittencourt MS; Goulart AC; Schmidt MI; Diniz MFHS; Lotufo PA; Benseñor IM
Atherosclerosis; 2017 May; 260():34-40. PubMed ID: 28340367
[TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74.
Dereziński T; Zozulińska-Ziółkiewicz D; Uruska A; Dąbrowski M
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3052. PubMed ID: 30064156
[TBL] [Abstract][Full Text] [Related]
9. Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?
Kim CS; Kim SK; Araneta MR; Lee EJ; Barrett-Connor E; Huh KB
J Diabetes Complications; 2015; 29(8):1085-91. PubMed ID: 26231803
[TBL] [Abstract][Full Text] [Related]
10. The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus.
Sung HH; Park CE; Gi MY; Cha JA; Moon AE; Kang JK; Seong JM; Lee JH; Yoon H
Endocr J; 2020 Jun; 67(6):613-621. PubMed ID: 32161204
[TBL] [Abstract][Full Text] [Related]
11. Effect of parental history of diabetes on markers of inflammation, insulin resistance and atherosclerosis in first degree relatives of patients with type 2 diabetes mellitus.
Dash DK; Choudhury AK; Singh M; Mangaraj S; Mohanty BK; Baliarsinha AK
Diabetes Metab Syndr; 2018 May; 12(3):285-289. PubMed ID: 29275995
[TBL] [Abstract][Full Text] [Related]
12. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
[TBL] [Abstract][Full Text] [Related]
13. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Hernández MJG; Klünder M; Nieto NG; Alvarenga JCL; Gil JV; Huerta SF; Siccha RQ; Hernandez J
Endocr Pract; 2018 Mar; 24(3):294-301. PubMed ID: 29547047
[TBL] [Abstract][Full Text] [Related]
14. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
[No Abstract] [Full Text] [Related]
15. Adiposity Phenotypes and Subclinical Atherosclerosis in Adults from Sub-Saharan Africa: An H3Africa AWI-Gen Study.
Nonterah EA; Bots ML; Oduro A; Agongo G; Soo CC; Micklesfield LK; Mashinya F; Boua PR; Mohamed SF; Wade AN; Kyobutungi C; Tinto H; Norris SA; Tollman SM; Ramsay M; Grobbee DE; Klipstein-Grobusch K; Crowther NJ;
Glob Heart; 2021 Mar; 16(1):19. PubMed ID: 33833943
[TBL] [Abstract][Full Text] [Related]
16. Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation.
Al-Daghri NM; Al-Attas OS; Alokail M; Alkharfy K; Wani K; Amer OE; Ul Haq S; Rahman S; Alnaami AM; Livadas S; Kollias A; Charalampidis P; Sabico S
Pediatr Res; 2014 Mar; 75(3):459-63. PubMed ID: 24296798
[TBL] [Abstract][Full Text] [Related]
17. Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus.
Randrianarisoa E; Lehn-Stefan A; Hieronimus A; Wagner R; Maucher J; Rittig K; Balletshofer B; Birkenfeld AL; Peter A; Stefan N; Häring HU; Fritsche A; Heni M
Sci Rep; 2020 Dec; 10(1):22453. PubMed ID: 33384433
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.
Haymana C; Sonmez A; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Arch Endocrinol Metab; 2017; 61(3):282-287. PubMed ID: 28225990
[TBL] [Abstract][Full Text] [Related]
19. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women.
Wildman RP; Janssen I; Khan UI; Thurston R; Barinas-Mitchell E; El Khoudary SR; Everson-Rose SA; Kazlauskaite R; Matthews KA; Sutton-Tyrrell K
Am J Clin Nutr; 2011 Apr; 93(4):719-26. PubMed ID: 21346089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
